HONG KONG,Feb. 13,2025--Akeso,Inc. (9926. HK) ("Akeso" or the "Company") announced the recent completion of the first patient enrollment in the Phase 3 randomized,double-blind,mult
02-13
Ranked among the top 1% of companies assessed in the pharmaceutical industry Recognized as a leader in Green CRDMO,driving innovation for a healthier future
02-11
CBL-514,the world\'s first investigational drug for large-area localized fat reduction,has demonstrated significant efficacy in its second and the last Phase 2b study (CBL-0205) before Phase 3.
02-11
NEW YORK,Feb. 10,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,t
02-11
LJUNGAVERK,Sweden,Feb. 10,2025-- Swedish-basedPermascand,owned by Altor,has merged with Magneto Special Anodes to form a global leader in catalytic coatings and electrodes for premium segment customer
02-11
HSINCHU,Feb. 10,2025 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS),an industry leading provider of
02-11
SHENZHEN,China,Feb. 10,2025--Taoping Inc. (Nasdaq: TAOP,the "Company"),a provider of innovative smart cloud platform services and solutions,today revealed that it has entered into a non-bind
02-11
LJUNGAVERK,Sweden,Feb. 10,2025-- Swedish-basedPermascand,owned by Altor,has merged with Magneto Special Anodes to form a global leader in catalytic coatings and electrodes for premium segment customer
02-11
- The new Global X AI Infrastructure ETF (3401)brings Mirae Asset\'s AI-themed lineup to six products,offering both active and passive strategies for comprehensive investment solutions.
02-11
- GCCL\'s "One-Stop Lab Solution" sets the industry benchmark with unmatched competitiveness and a dedication to global excellence.
02-10
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map
